|
Sign In to gain access to subscriptions and/or personal tools.
|
First published on June 18, 2008 Reproductive Sciences 2008, doi:10.1177/1933719108316984
Preeclampsia Risk and Angiotensinogen Polymorphisms M235T and AGT -217 in African American and Caucasian Women
Laura D. Jenkins, MD, MPH1*,
Robert W. Powers, PhD2,
Mary Cooper2,
Marcia J. Gallaher2,
Nina Markovic, PhD2,
Robert Ferrell, PhD3,
Roberta B. Ness, MD, MPH2,
and
James M. Roberts, MD4
1 University of Pittsburgh Medical Center
2 Magee-Womens Research Institute, University of Pittsburgh Medical Center
3 Pittsburgh Graduate School of Public Health
4 Magee-Womens Research Institute
* To whom correspondence should be addressed. E-mail: jenkinsld{at}upmc.edu.
 |
Abstract |
|---|
Introduction: Genetic variants of the angiotensinogen gene have been linked to both hypertension and preeclampsia.The M235T polymorphism is more common in hypertension and preeclampsia in some populations. A polymorphism in the angiotensinogen basal promoter region of AGT -217 is more common in African Americans with hypertension.The authors investigated the frequency of M235T and AGT -217 in Caucasian and African American women with and without preeclampsia. Methods:The study was a nested case–control study of primiparous women with singleton pregnancies. Genomic DNA from preeclamptic and control subjects underwent polymerase chain reaction amplification and restriction digestion. Results:The M235T and AGT -217 polymorphisms were both more common in African American women; however, the variants were not more common in preeclampsia. Conclusion: The frequency of angiotensinogen polymorphisms M235T and AGT -217 is different by race; however, these polymorphisms are not associated with an increased risk of preeclampsia.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|